{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "anti-virals",
      "clinical trials",
      "corticosteroids",
      "type I interferons (IFNs)"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33868280",
  "DateCompleted": {
    "Year": "2021",
    "Month": "05",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "22"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "03",
        "Day": "31"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "644850",
      "10.3389/fimmu.2021.644850"
    ],
    "Journal": {
      "ISSN": "1664-3224",
      "JournalIssue": {
        "Volume": "12",
        "PubDate": {
          "Year": "2021"
        }
      },
      "Title": "Frontiers in immunology",
      "ISOAbbreviation": "Front Immunol"
    },
    "ArticleTitle": "Why Haven't We Found an Effective Treatment for COVID-19?",
    "Pagination": {
      "StartPage": "644850",
      "MedlinePgn": "644850"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MDP Drug Discovery and Development, Institute of Biomedicine, Faculty of Medicine, University of Turku, Turku, Finland."
          }
        ],
        "LastName": "Spicer",
        "ForeName": "Alexander James",
        "Initials": "AJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MediCity Research Laboratory and Institute of Biomedicine, University of Turku, Turku, Finland."
          }
        ],
        "LastName": "Jalkanen",
        "ForeName": "Sirpa",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Front Immunol",
    "NlmUniqueID": "101560960",
    "ISSNLinking": "1664-3224"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "Front Immunol. 2021 Jul 05;12:714175",
      "PMID": "34290716"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "growth & development"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "SJ owns stocks of Faron Pharmaceuticals. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
}